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Prognostic Value of Left Atrium Remodeling after Primary 
Percutaneous Coronary Intervention in Patients with ST Elevation 
Acute Myocardial Infarction
The purpose of this study is to assess the relationship between left atrial (LA) size and 
outcome after acute myocardial infarction (AMI) in patients undergoing primary 
percutaneous coronary intervention (PCI) and to evaluate dynamic changes in LA size 
during long-term follow-up. Echocardiographic analyses were performed on 253 AMI 
patients (174 male and 79 female, 65.4 ± 13.7 yr) undergoing PCI. These subjects were 
studied at baseline and at 12 months. Clinical follow-up were done at 30.8 ± 7.5 months. 
We assessed LA volume index (LAVI) at AMI-onset and at 12-month. Change of LAVI was 
an independent predictor of new onset of atrial fibrillation or hospitalization for heart 
failure (P = 0.002). Subjects who survived the 12-month period displayed an increased 
LAVI mean of 1.86 ± 4.01 mL/m
2 (from 26.1 ± 8.6 to 28.0 ± 10.1 mL/m
2, P < 0.001). The 
subject group that displayed an increased LAVI correlated with a low left ventricular 
ejection fraction, large left ventricle systolic and diastolic dimensions and an enlarged LA 
size. In conclusion, change of LAVI is useful parameter to predict subsequent adverse 
cardiac event in AMI patients. Post-AMI echocardiographic evaluation of LAVI provides 
important prognostic information that is significantly greater than that obtained from 
clinical and laboratory parameters alone.
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INTRODUCTION
Echocardiographic assessment of the left ventricular (LV) func-
tion plays an integral role in the examination of patients with 
heart failure (HF) undergoing acute myocardial infarction. In 
addition to the evaluation of myocardial contractility, the pa-
rameters of diastolic function may be useful in the providing 
significant prognostic information and determining therapeu-
tic strategies (1-6). Over the past decade, several indicators have 
been established to predict poor prognosis in patients with chron-
ic HF, including age, etiology, left ventricular ejection fraction 
(LVEF), functional class, exercise capacity, pulmonary arterial 
pressures, and cardiac output (7-9). Left atrial (LA) size also has 
been used as an important predictor of prognosis both in the 
general population and in patients with heart diseases (10), such 
as LV dysfunction (11), aortic stenosis (12), mitral stenosis (13), 
mitral regurgitation (14), and atrial fibrillation (AF) (15). In this 
study, we assessed LAVI in patients who presented with their 
first acute myocardial infarction (AMI) and were treated with 
primary percutaneous coronary intervention (PCI). LA volume 
has been described as an important predictor of fatal acute myo-
cardial infarction (16-19), with smaller LA volume being associ-
ated with good prognosis even in patients with depressed sys-
tolic function (20). In patients suffered from AMI, the LA volume 
may serve as a surrogate marker for the measurement of chronic 
diastolic function and ventricular filling pressure, as it was less 
affected by acute hemodynamic changes than were transmitral 
Doppler measurements (21, 22). In this study, we assessed LAVI 
in patients who presented their first AMI and were treated with 
primary PCI.
MATERIALS AND METHODS
Study group
We evaluated 276 patients with AMI who underwent PCI in our 
department between January 2007 and December 2008. We per-
formed an echocardiography within 1 day to assess the LAVI 
and evaluated the LA remodeling severity during the 12-month 
follow-up period after AMI. Our study included 264 consecu-
tive patients (174 male and 79 female, 65.4 ± 13.7 yr) with a first Cho JH, et al.  •  Left Atrium Remodeling after Acute Myocardial Infarction
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ST-elevation AMI who underwent primary PCI. Twelve patients 
were excluded before analysis because of underlying heart fail-
ure and atrial fibrillation. AMI was identified by clinical symp-
toms, new 1-mm ST-segment elevation in 2 contiguous leads, 
identification of the culprit artery on coronary angiography, and 
an increase in serum troponin, at least a ‘three-fold-level’ higher 
than the upper limit of normal as defined in our laboratory (0.4 
IU). Inclusion criteria included the patient being 18 yr or more, 
undergoing primary PCI within 12 hr of hospital admission, the 
identification of the culprit artery on coronary angiography and 
the ability to give informed consent. Exclusion criteria were: Non-
coronary atherosclerotic etiology of AMI, cardiogenic shock, 
intra-aortic balloon pump, intravenous inotropic support, pre-
vious coronary artery bypass surgery, presence of paced rhythm, 
the development of complication and known chronic heart fail-
ure before the echocardiographic study, inability to assess 3 myo-
cardial segments on echocardiogram, and a history of cocaine 
or drug abuse. Hospital charts were reviewed for age, peak tro-
ponin level, lipid profile, electrocardiogram at the initial presen-
tation, angiographic findings before and after PCI, in-hospital 
complications, development of congestive heart failure, the need 
for urgent revascularization after PCI, and death. Echocardio-
graphic examinations were performed at a mean of 3.5 days after 
the AMI (baseline) and at 12 months after AMI. Clinical follow-
up was done for 30.8 ± 7.5 months. The median echocardio-
graphic follow-up was 12.5-months (Group I: 12.5 ± 0.7, Group 
II: 12.4 ± 0.8, P = 0.201). Demographic and clinical characteris-
tics of the included subjects are summarized in Table 1.
Ethics statement
The study protocol was reviewed and approved by the institu-
tional review board of the National Evidence-based Healthcare 
Collaborating Agency (PIRBII-002-1[2]). Informed consent was 
submitted by all of the subjects.
Echocardiographic analysis
The echocardiographic analysis was performed in the left lateral 
decubitus position at rest using conventional methods with a 
commercially available ultrasound system (Siemens, Warsaw, 
Poland). All echocardiographic studies were analyzed in the 
main laboratory at the Division of Cardiology of our institute. 
During 12-months of follow-up, 11 of 264 patients died (cardiac 
deaths, 7; non-cardiac deaths, 4). Echocardiographic analyses 
were collected for the remaining 253 patients at baseline and at 
12 months, and clinical follow-up was performed at 30.8 ± 7.5 
months through patients visits and telephone interview. 
  The protocol included calculation of the left ventricular ejec-
tion fraction (LVEF) by applying the biplane Simpson Method 
(with tracing of end-diastolic and end-systolic left ventricular 
endocardial border from apical 4-chamber and 2-chamber views 
in 2D echocardiography), assessment of mitral inflow pattern 
(in an apical 4-chamber view by using the pulse Doppler sam-
ple volume at the tips of the opened mitral valve leaflets), pulsed 
tissue Doppler analysis of the mitral annular motion. Chamber 
dimensions (both ventricles and left atrium) were measured 
from 2D-imaging in the parasternal long axis view. Antero-pos-
terior dimension of the atrium was measured during end systo-
le. Mitral regurgitation (MR) was graded with color flow imag-
ing. For wall motion analysis, a 16-segment model was used ac-
cording to recommendations by the American Society of Echo-
cardiography (23). Analysis of the Echocardiographic image was 
performed centrally by 2 expert investigators who were unaware 
of patients’ clinical, electrocardiographic, or angiographic data. 
The wall motion score was reached via consensus. A percentage 
of the wall motion abnormalities were obtained by dividing the 
number of akinetic, dyskinetic, and aneurysmal segments by the 
total number of segments evaluated. MR was considered mild 
when the regurgitant jet area occupied  > 5 and  < 20% of the LA 
area, moderate when it occupied  > 20 and  < 40%, and severe 
when it occupied more than 40% of the LA area (24). Mitral in-
flow Doppler echocardiographic indices were obtained for each 
patient. We classified diastolic dysfunction according to mitral 
inflow pattern. An E/A ratio  < 1 was accepted as an indication 
of delayed relaxation profile, E/A > 2 as typical for restriction, 
and values of E/A between 1 and 2 as either a normal or pseudo-
normal pattern. Pulsed tissue Doppler analysis of mitral annular 
motion was also applied. LA volume was assessed by the biplane 
area-length method from apical 4-and 2-chamber views at the 
end-systole from the frame preceding the mitral valve opening. 
LAVI was calculated as LA volume to body surface area ratio 
(mL/m
2). LA remodeling was assessed by looking at the change 
in the LAVI from baseline to 12 months. In all cases, we analyzed 
Table 1. Baseline characteristics and number of mitral inflow pattern in study popu-
lation (n = 264)
Parameters Findings, No. (%)
Age (yr)   65.2 ± 13.7
Male 182 (68.9)
Body mass index (kg/m
2) 24.2 ± 3.0
History of ischemic heart disease   33 (12.5)
Anterior myocardial infarction 131 (49.6)
Hypertension 124 (47.0)
Diabetes mellitus   78 (29.5)
Hypercholesteremia  11 (4.2)
Smoking  149 (56.4)
Killip class (≥ III)    32 (12.1)
Heart Rate   77.0 ± 21.0
Systolic blood pressure (mmHg) 130.3 ± 30.0
Diastolic blood pressure (mmHg)   81.3 ± 18.8
Successful PCI 257 (97.3)
Normal profile   83 (31.4)
Delayed relaxation profile  145 (54.9)
Pseudonormal profile  10 (3.8)
Restrictive profile    4 (1.5)
PCI, percutaneous coronary intervention.Cho JH, et al.  •  Left Atrium Remodeling after Acute Myocardial Infarction
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medical history and recorded cardiac events such as cause and 
time of death. After the 12-month follow-up echocardiogram 
was performed, patients were divided into two groups: decreased 
LAVI (group I) and increased LAVI (group II) group. Baseline 
echocardiographic data between these groups were compared. 
Relative risk of new onset AF and hospitalization due to exacer-
bation of heart failure was calculated and the resulting Kaplan-
Meier curves were compared.
Coronary angiography 
Selective coronary artery angiography was performed in multi-
ple views using Judkin’s technique. It was analyzed by an inde-
pendent cardiologist. The infarct-related artery was identified 
based on a Thrombolysis in the Myocardial Infarction grade 0 
to 2 flow, the presence of haziness, suggestive of thrombus, and 
a 75% narrowing in relation to the reference segment before the 
PCI. Thrombolysis in the Myocardial Infarction flow grade (0 to 3) 
after the PCI was also recorded (25). Significant coronary artery 
disease was defined as a 50% narrowing of the luminal diame-
ter of any of the 3 major vessels or a major branch. 
Statistical methods
All continuous data were expressed as means ± standard devia-
tions and means were compared using Student’s t-tests for un-
paired variables. Differences between patients were assessed 
by un-paired t-testing, and parameters frequencies were exam-
ined using the chi-square test. The differences between echocar-
diographic measurements of the 2 groups, changes over time 
within each group (time effect), and interaction effects were as-
sessed by repeated measures analysis of variance. Differences 
between groups with LAVI change was assessed by the one-way 
ANOVA and frequency of parameters by chi-square test. Cumu-
lative event rate of new atrial fibrillation onset, hospitalization 
with heart failure was assessed by the Kaplan-Meier method. 
The influence of LA remodeling during the 12-month risk of clin-
ical outcomes was evaluated by the Cox proportional hazards 
models. For a multivariable model, we included variables proved 
to be initial AMI-onset clinical predictors of mortality from the 
overall study. These included age, creatinine, Killip class, histo-
ry of diabetes and echocardiographic parameters (LVEF, E/A 
ratio, E/E’ ratio), which were found to have a prognostic value 
in prior studies. We also included the number of repeated revas-
cularization. A P value < 0.05 considered statistically significant. 
Statistical analysis was performed with SPSS 18.0 for Windows 
(SPSS Inc., Chicago, IL, USA).
  To calculate optimal cutoff values the receiver operating char-
acteristic (ROC) Analysis was performed. Sensitivity, specificity, 
predictive values, and accuracy were calculated by using typical 
formulas. The Kaplan-Meier survival analysis was applied for 
determining the parameters differentiating the groups into var-
ious prognoses. The multivariate enter logistic regression was 
performed to identify the independent predictors of adverse 
outcome. A P value < 0.05 was considered significant.
RESULTS
During the mean 30-month follow-up period of 253 patients 
with AMI, 26 subjects were hospitalized due to heart failure ex-
acerbation and 23 subjects developed atrial fibrillation. These 
subjects were divided into two groups; 115 with decreased LAVI 
(Group I) and 138 with increased LAVI (Group II). There were no 
significant differences in baseline clinical characteristics, medi-
cation and laboratory findings between the two groups (Tables 
2, 3), or in the 12-month persistent rate of medications includ-
Table 2. Baseline clinical characteristics and medications between groups
Parameters
  Group I  
  (n = 115)
  Group II  
  (n = 138)
P value
Age (yr)   64.5 ± 12.9   65.1 ± 14.1 0.761
Male     79 (68.7%)    95 (68.8%) 0.980
BMI (kg/m
2) 24.2 ± 3.2 24.2 ± 2.9 0.994
Hypertension     49 (42.6%)    67 (48.6%) 0.345
Diabetes Mellitus     33 (28.7%)    41 (29.7%) 0.860
Hypercholesteremia     6 (5.2%)    5 (3.6%) 0.536
Smoking (%) 67 (58.3) 79 (57.2) 0.871
Killip (≥ III)      13 (11.3%)    17 (12.3%) 0.804
Heart rate   75.8 ± 21.0   79.3 ± 23.3 0.214
Systolic BP mmHg 131.9 ± 29.3 129.6 ± 30.2 0.544
Diastolic BP mmHg   81.9 ± 18.8   80.9 ± 18.3 0.516
History of IHD  11 (9.6%)    19 (13.8%) 0.657
Ant MI     51 (44.3%)    71 (51.4%) 0.260
LAH    12 (10.4%)    17 (12.3%) 0.639
LVH    23 (20.0%)    22 (15.9%) 0.401
Aspirin 115 (100%) 138 (100%)
Clopidogrel  112 (98.2%)  135 (97.8%) 0.812
Beta blocker    71 (65.1%)    73 (55.3%) 0.121
ACE inhibitor or ARB    91 (79.1%)  114 (83.8%) 0.338
Diuretics    34 (29.6%)    42 (30.4%) 0.881
Statins    98 (85.2%)  121 (89.0%) 0.374
BP, blood pressure; IHD, ischemic heart disease; MI, myocardial infarction; LAH, left 
atrial hypertrophy; LVH, left ventricular hypertrophy; ACE, angiotensin-converting en-
zyme; ARB, angiotensin receptor blocker.
Table 3. Baseline laboratory findings between groups
Biochemical 
   parameters
  Group I   Group II P value
Glucose 179.2 ± 87.9 167.3 ± 70.9 0.234
Creatinine    1.22 ± 1.14   1.31 ± 1.60 0.571
TC 185.0 ± 45.0 187.7 ± 42.3 0.637
LDL-c 117.9 ± 37.5 118.0 ± 39.0 0.973
hs-CRP   0.81 ± 2.15   0.87 ± 2.42 0.882
BNP   404.2 ± 628.9   601.1 ± 782.8 0.032
CPK   1,622.1 ± 1,157.6   1,480.1 ± 1,127.1 0.325
CK-MB   171.4 ± 162.9   181.0 ± 187.9 0.667
TnI   17.6 ± 15.3   17.1 ± 15.4 0.784
TC, total cholesterol; LDL-c, low density lipoprotein cholesterol; hs-CRP, high sensi-
tive C-reactive protein; BNP, B-type natriuretic peptide; CPK, creatine phosphokinase; 
CK-MB, creatine kinase-MB isoenzyme; TnI, troponin I.Cho JH, et al.  •  Left Atrium Remodeling after Acute Myocardial Infarction
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ing beta blockers (Group I; 65 [59.1%], Group II; 82 [64.1%], P =  
0.431), renin-angiotensine system (RAS) blockers (Group I; 91 
[82.7%], Group II; 107 [84.3%], P = 0.195) and amiodarone (Group 
I; 0 [0%], Group II; 2 [1.4%], P = 0.195). Table 4 compares the 
echocardigraphic parameters of the group with decreased LAVI 
to those of the group with increased LAVI. Regarding the echo-
cardiographic parameters, the group with increased LAVI dis-
played significantly larger left ventricular systolic and diastolic 
dimension, lower LVEF values, and larger LA dimension (mea-
sured in the long axis view) (P < 0.01, for all parameters) com-
pared to the group with decreased LAVI. The classic echocar-
Table 4. Comparison of baseline echocardiographic parameters between groups
Parameters Group I Group II P value
EF    58.8 ± 11.8   52.7 ± 13.6 < 0.001
WMSI   1.20 ± 0.27   1.27 ± 0.34 0.105
LVd (mm) 50.7 ± 6.0 52.6 ± 7.0 0.029
LVs (mm) 34.1 ± 6.7 36.6 ± 7.3 0.008
LA diameter (mm) 33.0 ± 8.8   37.5 ± 10.2 < 0.001
Significant MR (II-III) 29 (25.7%) 39 (27.5%) 0.747
Ev (cm/sec)   0.73 ± 0.22   0.75 ± 0.31 0.421
Av (cm/sec)   0.79 ± 0.21   0.83 ± 0.25 0.307
E/A   0.97 ± 0.41   0.98 ± 0.54 0.796
Deceleration time (ms) 198.1 ± 71.5 188.7 ± 70.3 0.323
Ev/E´ 12.6 ± 5.0 13.2 ± 6.2 0.503
Normal profile 37 (35.6%) 45 (37.5%) 0.766
Delayed relaxation profile  66 (63.5%) 72 (60.0%) 0.595
Pseudonormal profile  6 (5.8%) 4 (3.3%) 0.370
Restrictive profile  1 (1.0%) 3 (2.5%) 0.386
EF, ejection fraction; WMSI, wall motion score index; MR, mitral regurgitation; E or A, 
v, t, dt, early or atrial mitral inflow velocity, time or deceleration time; E´, early diastolic 
m.a velocity; A´, atrial late diastolic m.a velocity; S´, systolic m.a velocity; Ev/E´, ratio 
of peak velicity of mitral inflow early phase to peak velocity of early mitral annulus 
motion.
Table 5. Baseline angiographic characteristics between groups
Angiography findings Group I Group II P value
Infarct-related artery
   LAD 
   Non-LAD 
   Diseased vessel number 
 
  47 (43.1%)
  62 (56.9%)
1.59 ± 0.71
 
  65 (48.1%)
  70 (51.9%)
1.66 ± 0.74
 
0.433
 
0.426
ACC/AHA  lesion type
   B1 
   B2 
   C 
 
  9 (8.3%)
  17 (15.6%)
  81 (74.3%)
 
  8 (5.9%)
  18 (13.3%)
109 (80.7%)
 
0.477
0.616
0.229
TIMI flow
   0
   I
   II
   III
 
  59 (54.1%)
  7 (6.4%)
  20 (18.3%)
  23 (21.1%)
 
  72 (53.3%)
10 (7.4%)
  26 (19.3%)
  27 (20.0%)
 
0.901
0.764
0.857
0.832
Successful PCI 110 (95.7%) 126 (92.8%) 0.331
LAD, left anterior descending artery; TIMI, Thrombolysis In Myocardial Infarction; PCI, 
percutaneous coronary intervention; ACC, American College of Cardiology; AHA, 
American Heart Association.
Table 6. Baseline clinical and echocardiographic characteristics according to changes in left atrial volume index during one year after acute myocardial infarction 
Parameters
LAVI change (mL/m
2)
< -1.4 (n = 65) -1.4 to 1.3 (n = 60)  1.4 to 4.6 (n = 63) > 4.6 (n = 64) P value
Age (yr)   63.8 ± 13.0   64.4 ± 13.0   65.4 ± 13.8   65.8 ± 14.7 0.837
Male, n (%) 43 (66.2%) 43 (71.7%) 45 (71.4%) 42 (65.6%) 0.816
Body mass index (kg/m
2) 23.9 ± 3.1 24.6 ± 3.2 24.8 ± 2.8 23.6 ± 2.8 0.094
Systolic B/P (mmHg) 133.7 ± 31.9 130.5 ± 26.3 128.4 ± 28.9 129.7 ± 31.9 0.779
Diastolic B/P (mmHg)   82.9 ± 20.4   80.3 ± 16.2   82.7 ± 17.8   79.1 ± 19.4 0.584
Heart Rate   75.7 ± 20.9   75.2 ± 18.9   79.7 ± 18.8   74.9 ± 22.8 0.056
Killip III-IV   9 (13.8%) 4 (6.7%) 8 (12.7%)   9 (14.1%) 0.547
BNP   452.3 ± 762.1   326.1 ± 375.8   526.0 ± 540.8   735.1 ± 995.5 0.018
Hypertension 27 (41.5%) 27 (45.0%) 28 (44.4%) 34 (53.1%) 0.590
Diabetes 21 (32.3%) 14 (23.3%) 20 (31.7%) 18 (28.1%) 0.674
Previous MI   9 (13.8%) 3 (5.0%)   9 (14.3%) 9 (14.1%) 0.310
Smoking 37 (56.9%) 37 (61.7%) 35 (55.6%) 37 (57.8%) 0.915
Ant. AMI 31 (47.7%) 26 (43.3%) 33 (52.4%) 31 (48.4%) 0.798
Clopidogrel 64 (100%) 58 (96.7%) 62 (98.4%) 62 (96.9%) 0.507
ACE-inhibitor  47 (72.3%) 53 (83.1%) 50 (79.4%) 51 (82.3%) 0.432
Beta blocker 42 (66.7%) 34 (63.0%) 36 (58.1%) 31 (50.8%) 0.311
Statin 59 (90.8%) 47 (79.7%) 58 (93.5%) 54 (84.4%) 0.092
LV-EDV (mL) 100.3 ± 26.0 105.6 ± 26.8 113.0 ± 38.8 114.2 ± 36.8 0.392
LV-ESV (mL)   54.0 ± 22.0   54.4 ± 16.0   60.7 ± 28.9   62.4 ± 32.5 0.575
LV-EF   58.6 ± 11.3   59.5 ± 13.1   51.1 ± 12.6   53.2 ± 13.9 < 0.001
E wave (cm/s)   0.73 ± 0.20   0.71 ± 0.23   0.73 ± 0.23   0.78 ± 0.39 0.583
A wave (cm/s)   0.78 ± 0.22   0.82 ± 0.20   0.82 ± 0.22   0.82 ± 0.29 0.720
E/A wave   1.00 ± 0.42   0.98 ± 0.63   0.94 ± 0.43   0.97 ± 0.44 0.914
Deceleration time (ms) 195.9 ± 75.5 198.9 ± 62.4 184.5 ± 61.6 193.6 ± 82.0 0.736
E/E´ 12.8 ± 5.5 12.5 ± 4.6 13.8 ± 6.5 12.5 ± 5.9 0.633
LAVI, left atrial volume index; B/P, blood pressure; BNP, B-type natriuretic peptide; MI, myocardial infarction; AMI, acute myocardial infarction; ACE, angiotensin-converting enzyme; 
LV-EDV, left ventricular end diastolic volume; LV-ESV, left ventricular end systolic volume; LV-EF, left ventricular ejection fraction; E or A, early or atrial mitral inflow velocity; E/E´, 
ratio of peak velicity of mitral inflow early phase to peak velocity of early mitral annulus motion.Cho JH, et al.  •  Left Atrium Remodeling after Acute Myocardial Infarction
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diographic diastolic parameters were not different between the 
two groups. The comparison of pulsed tissue Doppler variables 
showed no significant difference for ratio of early wave peak ve-
locity of the mitral inflow to peak velocity in early phase of the 
mitral annulus motion (Ev/E’) (Table 4). The cut-off value of 
poor outcome was connected with the baseline LAVI at 26.5 
mL/m
2 (sensitivity = 70.5%, specificity = 65.3%, positve predic-
tive value = 29%, negative predictive value = 91.7%).
Left atrial remodeling
In the 253 patients for whom we completed echocardiographic 
follow-up at the 12-month period, the LAVI increased from 
26.1 ± 8.6 at baseline to 28.0 ± 10.1 mL/m
2 (P < 0.001) at 12 
months. The overall increase in LAVI over the 12-month period 
was 1.86 ± 4.01 mL/m
2. Increases in the LA volume from base-
line to 12 months was observed in 138 patients, while decreases 
were observed in 115 patients. The increased LAVI group sub-
jects had lower LVEF values, larger left ventricular systolic and 
diastolic dimension, and larger LA dimension, compared to the 
decreased LAVI group subjects. LA remodeling was not signifi-
cantly related to age, sex, hypertension, diabetes, heart rate, base-
line Killip class, wall motion score index and location of AMI, 
and echocardiographic classic diastolic parameters (Tables 2, 4, 
5). An increase in LAVI (in the highest compared to lowest quar-
tile) was associated with B-type natriuretic peptide (BNP), LVEF 
(Table 6). Changes in the LAVI were related to change of the LA 
volume and LVEF, but not significant MR (Table 7).
Left atrial remodeling and clinical outcome
LA-remodeling during the 12 months post-AMI was a predictor 
of atrial fibrillation, HF hospitalization, even after adjustment 
for baseling LAVI and covariates (Tables 8, 9). Fig. 1 shows the 
Kaplan-Meier estimates of adverse cardiac events (new onset 
atrial fibrillation, hospitalization with heart failure) according 
Table 7. Comparison of echocardiographic parameters in both groups baseline and 1 yr
Parameters Group I Group II
P 
(between groups)
LAV
   Baseline
   1 yr
   P (within groups)
 
41.5 ± 9.6
38.5 ± 9.6
< 0.001
 
  45.4 ± 12.3
  51.6 ± 12.6
< 0.001
 
0.004
< 0.001
LAVI
   Baseline
   1 yr
   P (within groups)
 
24.2 ± 6.6
22.5 ± 6.6
< 0.001
 
27.9 ± 9.7
  32.7 ± 10.4
< 0.001
 
< 0.001
< 0.001
LV-Ejection fraction
   Baseline
   1 yr
   P (within groups)
 
  58.2 ± 11.6
62.0 ± 9.4
0.029
 
  52.6 ± 13.5
  51.8 ± 12.4
0.313
 
< 0.001
< 0.001
Significant MR (grade II-III)
   Baseline
   1 yr
   P (within groups)
29 (25.7%)
23 (20.4%)
0.109
39 (27.5%)
38 (26.8%)
0.797
0.747
0.234
LAV, left atrial volume; LAVI, left atrial volume index; MR, mitral regurgitation.
Table 8. Major adverse cardiac events between groups
Events Group I Group II P value
Death 1 (0.9%) 2 (1.4%) 0.700
Atrial fibrillation 5 (4.4%) 18 (12.7%) 0.022
Hospitalization with HF 2 (1.8%) 25 (17.6%) < 0.001
Revascularization  3 (2.7%) 3 (2.1%) 0.777
HF, heart failure.
Table 9. Risk of adverse events for each ml/m
2 increase in left atrial volume index at 12 months compared with baseline size
Cardiac events  HR Lower 95% CI Upper 95% CI P value
Heart failure
   hopspitalization
Unadjusted
Adjusted
a
Adjusted
b
1.209
1.177
1.223
1.094
1.047
1.055
1.337
1.323
1.419
< 0.001
0.006
0.008
Atrial fibrillation Unadjusted
Adjusted
a
Adjusted
b
1.183
1.148
1.193
1.067
1.025
1.054
1.313
1.286
1.350
0.001
0.017
0.005
Heart failure 
   hopspitalization or
   Atrial fibrillation
Unadjusted
Adjusted
a
Adjusted
b
1.194
1.173
1.216
1.097
1.068
1.091
1.299
1.289
1.354
< 0.001
0.001
< 0.001
Adjusted
a for baseline left atrial volume index (LAVI). Adjusted
b for baseline LAVI, Age, BMI, heart rate, Killip class, history of ischemic heart disease, Diabetes Mellitus, BNP,  re-
vascularization, anterior wall myocardial infarction, LV ejection fraction.
Fig. 1. New onset atrial fibrillation or hospitalization with heart failure according to 
change of LAVI (P value = 0.002). 
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to this classification. The cut-off value of poor outcome that was 
related to the changes in LAVI was 1.14 mL/m
2 (sensitivity =  
75%, specificity = 55%, positive predictive value = 26%, nega-
tive predictive value = 91.2%).
DISCUSSION
The major finding of this study is that LAVI was proofed as a 
good prognostic factor for AMI after primary PCI. Noninvasive 
assessment of LAVI at initial AMI-onset provides superior long-
term prognostic information compared with clinical systolic 
and diastolic echocardiographic variables such as myocardial 
tissue function assessment by using tissue Doppler imaging. This 
study demonstrated that change of LAVI is a predictor of a new- 
onset atrial fibrillation and hospitalization for heart failure after 
in patients undergoing primary PCI. It was already known that 
baseline LA size is an independent predictor of death or hospi-
talization for HF in patients suffering from an AMI. LA remod-
eling begins early after AMI (17) and is influenced by EF, left ven-
tricular dimension, wall motion score/16. LA remodeling is pre-
dictive of mortality and cardiovascular morbidity.
  The LA size is considered to be an expression of the diastolic 
burden and an increased LA volume usually reflects elevated 
ventricular filling pressure. During ventricular diastole, the left 
atrium is directly exposed to LV pressure through the open mi-
tral valve. As an adaptation to the decreased ventricular com-
pliance following an AMI, the LA pressure rises. This increases 
the LA wall tension and stretches the atrial myocardium; LA 
volume reflects the duration and severity of the increased LA 
pressure (21, 22). In the setting of an AMI, patients with higher 
chronic LV filling pressure and a previously worsened diastolic 
dysfunction have lower hemodynamic ‘cardiac reserve’ to help 
them withstand acute decreases in myocardial contraction (16). 
In the early period after AMI, the LA size has shown to provide 
prognostic information in addition to clinical data and standard 
echocardiographic predictors (15-17). The present study con-
firms and extends these conclusions to a population of patients 
with AMI and shows that LA size is a predictor of not only of mor-
tality but also of cardiovascular morbidity. The increased risk 
associated with a greater LA size appears to be continuous, and 
even patients with a mild increase in LA size are at increased 
risk. We observed that in post-AMI, LA size was a better prog-
nostic predictor of outcome than transmitral Doppler indices. 
Doppler indices may be quite sensitive to acute changes in the 
loading conditions secondary to HF and/or to drugs (26, 27). 
On the contrary, LA volume is likely to be less affected by acute 
hemodynamic changes and may represent a more stable indi-
cator of the duration and severity of diastolic function and fill-
ing pressure over time (22). Likewise, deceleration time, which 
is a dominant predictor of outcome when in the frankly restric-
tive range (28), is less useful when  > 140 ms. After an AMI, ven-
tricular structure and functional alteration can lead to ventricu-
lar relaxation abnormalities resulting in worsening of diastolic 
dysfunction and LA remodeling. In our acute MI data, increased 
LAVI was associated with lower LVEF, atrial fibrillation and LV 
and LA enlargement in this population. All of these factors are 
already known to increase LV filling pressure and therefore in-
fluence LA volume. LAVI values were not significantly related 
to gender, diabetes, hypertension, heart rate, Killip class, renal 
impairment and diastolic echocardiographic parameters. The 
main finding of our study is that measurement of baseline and 
changed LAVI values is a strong and useful predictor of adverse 
events in post-AMI patients undergoing PCI. Interestingly, nei-
ther systolic nor diastolic function parameters retained statisti-
cal significance in multivariate analysis, although the left ven-
tricular EF and the enlarged dimensions of the left ventricle are 
classic predictors of cardiac mortality after AMI (29), recently 
published studies emphasize the significance of diastolic param-
eters to enable further prognostic stratification, especially in 
groups with more uniform types of systolic dysfunction (e.g., 
patients after anterior AMI or below some level of EF impair-
ment) (30). Some limitation of the present study should be not-
ed. The entry criterion for the study was measurement of change 
of LAVI. Measurements of LA volume were obtained by multi-
ple observers working in a clinical environment, which suggests 
that the findings can be widely applied. The Doppler assessment 
may have resulted in a misclassification of diastolic function in 
several cases (for example, in some patients with normal Dop-
pler parameters who had LA enlargement and vice versa). 
  In patients experiencing AMI followed by primary PCI, the 
LA size is an independent predictor of both mortality and cardio-
vascular morbidity. Moreover, changes in LA size in the months 
following an AMI predict subsequent adverse outcomes. These 
data suggest that the assessment of baseline and changing LAVI 
values is a potential surrogate for LA remodeling in patients un-
dergoing PCI after AMI, represents an additions to post-AMI 
echocardiographic evaluation, and provides more accurate prog-
nostic information than that obtained from clinical and labora-
tory parameters alone.
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